0115 837 0503 info@aureliabio.com

Blog: Research in Oncology: The fight continues

Cancer is a group of multifactorial diseases with complex genesis and progression. Irrespective of the type, all tumour cells are characterised by their ability to grow, invade and metastasise in an unregulated manner. According to statistics, around 9.6 million...

Blog: Synergy between CROs and their client partners

As innovations in drug discovery continue to abound, the relationship between pharmaceutical/ biotechnology industry and CROs (Contract Research Organisations) has strengthened significantly. However, choosing the right CRO for a project is not always straightforward....

New service launch: Kinase Compound Profiling

Aurelia Bioscience now offers kinase compound profiling services using Promega’s NanoBRET™ Target Engagement (TE) Intracellular Kinase Assays: http://bit.ly/2BVzzo0 Are you looking to screen your compounds against specific kinase targets? Get in touch with our...

Autophagy webinar

Gary Allenby, CSO, Aurelia Bioscience participated in a webinar on ‘A Multimodal Assay for Quantitating and Interpreting Changes in Autophagic Flux’ hosted by Promega. Follow the link to watch the full webinar.  

New Video!

Watch this video to learn how Aurelia Bioscience used electrospun micro-scaffold technology to develop 3D cell structures that better imitate physiological conditions for cell-based assays.